Article info
Clinical and epidemiological research
Extended report
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
- Correspondence to Professor C P Denton, Centre for Rheumatology, Royal Free Hospital, Pond Street, London NW3 2QG, UK; c.denton{at}medsch.ucl.ac.uk
Citation
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
Publication history
- Accepted August 22, 2008
- First published September 9, 2008.
Online issue publication
August 12, 2009
Article Versions
- Previous version (9 September 2008).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd and European League Against Rheumatism. All rights reserved.